Aflatoxin B1/B2 Antibody (3501): sc-58087
- Aflatoxin B1/B2 Antibody (3501) is a mouse monoclonal IgG1 Aflatoxin B1/B2 antibody provided at 100 µg/ml
- raised against aflatoxin of Aspergillus flavus origin
- recommended for detection of B1 and B2 aflatoxins of Aspergillus flavus origin by ELISA
- At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for Aflatoxin B1/B2 Antibody (3501). This work is in progress.
QUICK LINKS
Aflatoxin B1/B2 Antibody (3501) is a mouse monoclonal IgG1 antibody that detects Aflatoxin B1/B2 protein of Aspergillus flavus origin by enzyme-linked immunosorbent assay (ELISA). Anti-Aflatoxin B1/B2 antibody (3501) is available as the non-conjugated monoclonal isotype antibody. Aflatoxins are toxic metabolites produced by certain molds, primarily Aspergillus flavus and Aspergillus parasiticus, which thrive in warm and humid environments. Aflatoxin B1, in particular, is recognized as one of the most potent carcinogens known, posing significant health risks to both humans and animals when ingested through contaminated food sources. The presence of Aflatoxin B1 in agricultural products can lead to severe economic losses and regulatory challenges, making detection crucial for food safety. Aflatoxin B1/B2 monoclonal antibody (3501) plays a vital role in monitoring and quantifying these mycotoxins, thereby aiding in the prevention of aflatoxicosis and ensuring compliance with food safety standards. Anti-Aflatoxin B1/B2 antibody (3501) specificity allows for accurate detection, which is essential for assessing exposure risk and implementing appropriate safety measures in food production and storage.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Aflatoxin B1/B2 Antibody (3501) References:
- Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias. | Schick, V., et al. 2006. Acta Neuropathol. 112: 715-25. PMID: 17013611
- Carboxy-Terminal Modulator Protein (CTMP) is a mitochondrial protein that sensitizes cells to apoptosis. | Parcellier, A., et al. 2009. Cell Signal. 21: 639-50. PMID: 19168129
- Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma. | Simon, PO., et al. 2009. Int J Cancer. 125: 942-51. PMID: 19405118
- Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice. | Shin, JY., et al. 2013. Cancer Gene Ther. 20: 186-94. PMID: 23392203
- Small interfering RNA directed against CTMP reduces acute traumatic brain injury in a mouse model by activating Akt. | Zhao, S., et al. 2014. Neurol Res. 36: 483-90. PMID: 24670215
- Novel link of anti-apoptotic ATF3 with pro-apoptotic CTMP in the ischemic brain. | Huang, CY., et al. 2015. Mol Neurobiol. 51: 543-57. PMID: 24771044
- In Vitro Neurochemical Assessment of Methylphenidate and Its 'Legal High' Analogs 3,4-CTMP and Ethylphenidate in Rat Nucleus Accumbens and Bed Nucleus of the Stria Terminalis. | Davidson, C., et al. 2018. Front Psychiatry. 9: 149. PMID: 29892233
- Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway. | Liu, X., et al. 2018. J Am Heart Assoc. 7: PMID: 29945911
- Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer. | Lin, CH., et al. 2023. Cancer Gene Ther. 30: 404-413. PMID: 36400965
- PRAME promotes proliferation of multiple myeloma cells through CTMP/Akt/p21/CCND3 axis by ubiquitinating CTMP and p21. | Sun, K., et al. 2024. Heliyon. 10: e34094. PMID: 39071619
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Aflatoxin B1/B2 Antibody (3501) | sc-58087 | 100 µg/ml | $322.00 |